Outcomes of patients with relapsed or refractory acute myeloid leukemia: a population-based real-world study.
Joseph Brandwein, Lalit Saini, Michelle Geddes, Dimas Yusuf, Fei Liu, Kiersten Schwann, Alkarim Billawala, Christopher Westcott, Jessica A. Kurniawan, Winson Y. Cheung
Abstract
<0.001). Patients who received treatment (IT or NIT) had better survival than those who received only BSC. This study emphasizes the need for newer therapy options for patients with RR-AML.
Topics & Concepts
MedicineMyeloid leukemiaInternal medicineRefractory (planetary science)Confidence intervalPopulationCohortCancer registryRelative riskCancerPhysicsAstrobiologyEnvironmental healthAcute Myeloid Leukemia ResearchHematological disorders and diagnosticsNeutropenia and Cancer Infections